PTPRC and cancer: Large tumors have many cancer cells to target [80% of all tumor cells are cancer cells vs 35% of cancer cells in small CT26 tumors (18)], and large CT26 tumors also have a higher population of myeloid cells among all immune cells within TME (87% of CD45+ cells).